Telehealth Monitoring in Inflammatory Bowel Disease: Effects on Medication Compliance, Self-Efficacy, and Quality of Life
Recruiting · NCT06971627 · Interventional (participants receive a specific treatment) · Lead sponsor: Istanbul University - Cerrahpasa
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This randomized controlled trial aims to evaluate the effect of nurse-led telehealth monitoring on medication adherence, self-efficacy, and quality of life in individuals with inflammatory bowel disease (IBD). The study will be conducted at the IBD Outpatient Clinic of Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty. Participants will be randomly assigned to either an intervention group receiving a 3-month structured telehealth program (including education, counseling, phone calls, and reminders) or a control group receiving only standard care and an educational booklet. Outcomes will be assessed at baseline and after 12 weeks.
Who can take part
Inclusion criteria
- Individuals aged 18 years or older
- Individuals aged 18 years or older
- Able to read and write in Turkish
- Diagnosed with inflammatory bowel disease (IBD) for at least 6 months
- In clinical remission (Harvey-Bradshaw Index score \< 5 or Simple Clinical Colitis Activity Index score \< 3)
- Able to use a smartphone
- Have access to an online messaging application (e.g., WhatsApp) and a valid e-mail address
- Capable of downloading and using a mobile or computer-based video conferencing application (e.g., Zoom)
- Willing to participate in the study voluntarily
Exclusion criteria
- Diagnosed with any psychiatric or cognitive disorder
- Having any condition that impairs communication
- Pregnant women
- Patients receiving infusion-based treatment
- Having an advanced chronic disease
Where it is running
1 location listed.
- Istanbul University - Cerrahpasa Cerrahpaşa Faculty of Medicine Department of Gastroenterology - Istanbul, Turkey (Türkiye)